Turning Innovation
Into Health

Learn More

Venture Investors Health Fund is shaping the future of healthcare.

Based in the heart of the Midwest, we leverage our proximity to world-class research universities and dynamic communities to discover and invest in groundbreaking healthcare innovations.

With decades of experience and $275 million in assets under management, we are committed to fueling the next wave of transformative health solutions that improve lives and drive the future of health.

“I routinely recommend VI to other startup founders and I used the proceeds from an exit to invest in their last fund. I obviously trust and like the team.”

Rock Mackie, Tomotherapy, Co-Founder

“VI values personal interaction—they work well collaboratively. I count them as my friends now.”

Dan Stinchcomb, Inviragen, Co-Founder

“We became, overnight, a much more solid and substantial enterprise due to the investment.”

Lloyd Smith, ThirdWave Molecular Diagnostics, Co-Founder

Jim and the VI team were always there — composed and determined to lead us through thick and thin, for which I am and will always be grateful.”

Dr. Zhen Xu, Co-Founder of HistoSonics

"Jim and Venture Investors believe in the ViaLase team, and they are always ready to roll up their sleeves and help us."

Tibor Juhasz, Co-Founder of ViaLase, Intralase & LensX, with his mentor Gérard Mourou, recipient of The Nobel Prize in Physics 2018

Featured News

Venture Investors Health Fund Promotes Jenni Le to Principal, Expanding Commitment to University Spinouts and Healthcare Innovation.

Jenni has been a driving force since joining VI in 2022, making an incredible impact on our portfolio and the healthcare innovation ecosystem. From her work with Visana Health to strengthening connections in Wisconsin’s vibrant research community, Jenni’s dedication and talent have been nothing short of inspiring. As a proud UW-Madison alum, Jenni embodies the “Wisconsin Idea” by helping transform groundbreaking research into real-world healthcare solutions.

Learn More

Featured News

Venture Investors Health Fund Promotes Jenni Le to Principal, Expanding Commitment to University Spinouts and Healthcare Innovation.

Click Here

Featured Portfolios

LenSx developed a breakthrough, image-guided femtosecond surgical laser suite to perform refractive cataract surgery.

Results: The company was acquired by Alcon for up to $744 million.

Learn More

NeuWave Medical invented and commercialized a minimally invasive device to ablate cancer using microwave energy.

Results: With rapidly growing revenue, NeuWave Medical was acquired by Ethicon, a division of Johnson & Johnson.

Learn More

TomoTherapy developed image guided therapy to precisely deliver radiation dosages, while sparing healthy tissue.

Results: TomoTherapy completed the fourth largest healthcare IPO in the first decade of the millennium in 2007, and Venture Investors returned $75 million on a $7.5 million investment.

IntraLase developed a laser system that enabled a "bladeless" LASIK procedure for vision correction.

Results: IntraLase went public and was later acquired by Abbott for $808 million.

Learn More

Inviragen developed a vaccine to protect against dengue fever, a disease that threatens 2.5 billion people across the globe.

Results: Inviragen was acquired by Takeda for up to $250 million.

Learn More

NimbleGen is the leading supplier of flexible high-density microarray products, enabling a new era of “High Definition Genomics.”

Results: NimbleGen was acquired by Roche for $270 million.

Learn More

ThirdWave Molecular Diagnostics is a diagnostics company that created tests for HPV virus, a sexually transmitted infection that can cause cervical cancer.

Results: Third Wave was acquired by Hologic for $580 million.

Learn More